This Tmprss2-CreERT2 knock-in strain is highly efficient and allows precise control over the timing of introducing gene alterations in the mouse prostate and colon, and accurately mimics the late onset of human prostate cancer and colon cancer. The gene discussed is TMPRSS2; the disease is colonic neoplasm.